Worth Venture Partners’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-511,900
Closed -$316K 102
2020
Q3
$316K Buy
511,900
+72,100
+16% +$3.05M 0.26% 77
2020
Q2
$2.31M Buy
439,800
+321,100
+271% +$16.4M 1.13% 16
2020
Q1
$706K Buy
118,700
+94,000
+381% +$4.25M 0.43% 36
2019
Q4
$210K Buy
24,700
+10,700
+76% +$436K 0.1% 70
2019
Q3
$91K Buy
+14,000
New +$590K 0.05% 78

Other funds holding ATEX

Worth Venture Partners's ATEX Position: Q3 2019 in Review

Worth Venture Partners sold out of Anterix (ATEX) in Q3 2019, closing a stake of 2,257 shares — an estimated $95.1K sold.

Worth Venture Partners first reported a position in ATEX in Q4 2018 and held it in 3 quarters. The position peaked at $107K in Q2 2019. 75 funds tracked by Wall St. Rank hold ATEX as of Q3 2019.

  • Worth Venture Partners reported no remaining Anterix position as of Q3 2019 after selling out during the quarter.
  • Worth Venture Partners sold 2,257 Anterix shares in Q3 2019, an estimated $95.1K.
  • Worth Venture Partners first reported a position in Anterix in Q4 2018 and held it in 3 quarters.
  • Worth Venture Partners's Anterix position peaked at $107K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Anterix as of Q3 2019.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.